Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping

While it is evident that the carboxyl‐terminal region of natural peptide ligands bind to the amino‐terminal domain of class B GPCRs, how their biologically critical amino‐terminal regions dock to the receptor is unclear. We utilize cysteine trapping to systematically explore spatial approximations among residues in the first five positions of secretin and in every position within the receptor extracellular loops (ECLs). Only Cys2 and Cys5 secretin analogues exhibited full activity and retained moderate binding affinity (IC50: 92±4 and 83±1 nM, respectively). When these peptides probed 61 human secretin receptor cysteine‐replacement mutants, a broad network of receptor residues could form disulfide bonds consistent with a dynamic ligand‐receptor interface. Two distinct patterns of disulfide bond formation were observed: Cys2 predominantly labeled residues in the amino terminus of ECL2 and ECL3 (relative labeling intensity: Ser340, 94±7%; Pro341, 84±9%; Phe258, 73±5%; Trp274 62±8%), and Cys5 labeled those in the carboxyl terminus of ECL2 and ECL3 (Gln348, 100%; Ile347, 73±12%; Glu342, 59±10%; Phe351, 58±11%). These constraints were utilized in molecular modeling, providing improved understanding of the structure of the transmembrane bundle and interconnecting loops, the orientation between receptor domains, and the molecular basis of ligand docking. Key spatial approximations between peptide and receptor predicted by this model (H1‐W274, D3‐N268, G4‐F258) were supported by mutagenesis and residue‐residue complementation studies.—Dong, M., Xu, X., Ball, A. M., Makhoul, J. A., Lam, P. C.‐H., Pinon, D. I., Orry, A., Sexton, P. M., Abagyan, R., Miller, L. J. Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping. FASEB J. 26, 5092–5105 (2012). www.fasebj.org

[1]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[2]  H. Jüppner,et al.  Identification of Determinants of Inverse Agonism in a Constitutively Active Parathyroid Hormone/Parathyroid Hormone-related Peptide Receptor by Photoaffinity Cross-linking and Mutational Analysis* , 2001, The Journal of Biological Chemistry.

[3]  D. Drucker,et al.  International Union of Pharmacology. XXXV. The Glucagon Receptor Family , 2003, Pharmacological Reviews.

[4]  C. Sander,et al.  Errors in protein structures , 1996, Nature.

[5]  A. Couvineau,et al.  Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  P. Robberecht,et al.  Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC2: role of basic residues in the second transmembrane helix , 2001, British journal of pharmacology.

[7]  L. Miller,et al.  Importance of each residue within secretin for receptor binding and biological activity. , 2011, Biochemistry.

[8]  Elizabeth Buck,et al.  Site-specific Disulfide Capture of Agonist and Antagonist Peptides on the C5a Receptor* , 2005, Journal of Biological Chemistry.

[9]  L. Miller,et al.  Differential determinants for coupling of distinct G proteins with the class B secretin receptor. , 2012, American journal of physiology. Cell physiology.

[10]  Albert C. Pan,et al.  Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor , 2012, Nature.

[11]  P. Robberecht,et al.  Two Basic Residues of the h-VPAC1 Receptor Second Transmembrane Helix Are Essential for Ligand Binding and Signal Transduction* , 2001, The Journal of Biological Chemistry.

[12]  Laurence J Miller,et al.  Spatial Approximations between Residues 6 and 12 in the Amino-terminal Region of Glucagon-like Peptide 1 and Its Receptor , 2010, The Journal of Biological Chemistry.

[13]  B. Wulff,et al.  Three Distinct Epitopes on the Extracellular Face of the Glucagon Receptor Determine Specificity for the Glucagon Amino Terminus* , 2003, Journal of Biological Chemistry.

[14]  R. Heinzen,et al.  Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii , 2007, Cellular microbiology.

[15]  M. Fan,et al.  Transmembrane Residues of the Parathyroid Hormone (PTH)/PTH-related Peptide Receptor That Specifically Affect Binding and Signaling by Agonist Ligands* , 1996, The Journal of Biological Chemistry.

[16]  B Sollner-Webb,et al.  High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment. , 1984, Nucleic acids research.

[17]  R. Rudolph,et al.  Passing the baton in class B GPCRs: peptide hormone activation via helix induction? , 2009, Trends in biochemical sciences.

[18]  R. Abagyan,et al.  Spatial Approximation between Secretin Residue Five and the Third Extracellular Loop of Its Receptor Provides New Insight into the Molecular Basis of Natural Agonist Binding , 2008, Molecular Pharmacology.

[19]  Elizabeth Buck,et al.  Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Gardner,et al.  Interaction of synthetic 10-tyrosyl analogues of secretin with hormone receptors on pancreatic acinar cells. , 1977, Gastroenterology.

[21]  P. de Neef,et al.  Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor. , 1999, Receptors & channels.

[22]  Jean-Luc Pellequer,et al.  Multi‐template approach to modeling engineered disulfide bonds , 2006, Proteins.

[23]  Angela Wittelsberger,et al.  Mapping peptide hormone-receptor interactions using a disulfide-trapping approach. , 2008, Biochemistry.

[24]  G. Bitan,et al.  Photoaffinity Cross-linking Identifies Differences in the Interactions of an Agonist and an Antagonist with the Parathyroid Hormone/Parathyroid Hormone-related Protein Receptor* , 2000, The Journal of Biological Chemistry.

[25]  Ruben Abagyan,et al.  ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..

[26]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[27]  P. de Neef,et al.  Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin , 1998, FEBS letters.

[28]  Ruben Abagyan,et al.  Functional Importance of a Structurally Distinct Homodimeric Complex of the Family B G Protein-Coupled Secretin Receptor , 2009, Molecular Pharmacology.

[29]  L. Miller,et al.  Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides. , 2009, International journal of peptide and protein research.

[30]  T. Lybrand,et al.  Spatial Approximation between the Amino Terminus of a Peptide Agonist and the Top of the Sixth Transmembrane Segment of the Secretin Receptor* , 2004, Journal of Biological Chemistry.

[31]  D. Drucker,et al.  The Glucagon Receptor Family , 2000 .

[32]  R. Rudolph,et al.  Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor , 2007, Proceedings of the National Academy of Sciences.

[33]  Ruben Abagyan,et al.  Molecular Basis of Secretin Docking to Its Intact Receptor Using Multiple Photolabile Probes Distributed throughout the Pharmacophore* , 2011, The Journal of Biological Chemistry.

[34]  Brian K Shoichet,et al.  Structure-based drug screening for G-protein-coupled receptors. , 2012, Trends in pharmacological sciences.

[35]  A. Couvineau,et al.  Class-B GPCR activation: is ligand helix-capping the key? , 2008, Trends in biochemical sciences.

[36]  M. Beyermann,et al.  Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues. , 2005, Biochemistry.

[37]  L. Miller,et al.  Multiple Extracellular Loop Domains Contribute Critical Determinants for Agonist Binding and Activation of the Secretin Receptor* , 1996, The Journal of Biological Chemistry.

[38]  L. Miller,et al.  Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor* , 2007, Journal of Biological Chemistry.

[39]  Arthur Christopoulos,et al.  Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands* , 2007, Journal of Biological Chemistry.

[40]  C. Ulrich,et al.  Molecular cloning and functional expression of a human pancreatic secretin receptor. , 1995, Biochemical and biophysical research communications.

[41]  Ian S. Hagemann,et al.  Structure of the Complement Factor 5a Receptor-Ligand Complex Studied by Disulfide Trapping and Molecular Modeling* , 2008, Journal of Biological Chemistry.

[42]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[43]  S. Datta,et al.  Packing-induced Conformational and Functional Changes in the Subunits of α-Crystallin* , 2000, The Journal of Biological Chemistry.

[44]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.